ADAR and breast carcinoma: Using shRNAs, we knocked down DHX9 in two ADAR1-independent breast cancer lines, MCF-7 and SK-BR-3 (Fig. 4A–B and F–G; Supplementary Fig. S5A–S5B and S5G–S5H).